Solborn

Solborn Equity

The The Equity of Solborn (035610.KQ) as of Oct 18, 2026 is 212.61 B KRW. In the previous year, The Equity was 206.50 B KRW — a change of 2.96% (higher).

Equity

212.61 BKRW

YoY

2.96%

Last updated:

In 2025, Solborn's equity was 212.61 B KRW, a 2.96% increase from the 206.50 B KRW equity in the previous year.

The Solborn Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
138.76 B KRW
Jan 1, 2019
140.28 B KRW
Jan 1, 2020
138.68 B KRW
Jan 1, 2021
161.60 B KRW
Jan 1, 2022
123.84 B KRW
Jan 1, 2023
164.74 B KRW
Jan 1, 2024
206.50 B KRW
Jan 1, 2025
212.61 B KRW
The Solborn Equity history
YEAREquityYoY
212.61 BKRW+2.96%
206.50 BKRW+25.35%
164.74 BKRW+33.03%
123.84 BKRW-23.37%
161.60 BKRW+16.53%
138.68 BKRW-1.14%
140.28 BKRW+1.10%
138.76 BKRW+8.82%
127.51 BKRW-1.04%
128.86 BKRW+0.07%
128.76 BKRW+4.22%
123.54 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solborn Stock analysis

What does Solborn do? Solborn Inc, identified by the ticker symbol 035610.KQ and ISIN KR7035610005, is a South Korean enterprise operating within the Health Care sector. Headquartered in Seoul, the company went public on August 13, 1999, and maintains a digital presence at http://www.solborn.co.kr/. Despite its classification in the health care industry, Solborn functions primarily as a holding company that engages in the participation and management advisory of other firms through shareholding. The organization currently employs nine full-time staff members who oversee its diverse portfolio of subsidiaries and assets. A significant portion of its holding business involves the investment and management of its subsidiary companies, most notably INFINITT Healthcare Co., Ltd. This subsidiary is engaged in the manufacture of medical image processing systems, which include picture archiving and communication systems, commonly known as PACS. These systems are critical tools in modern healthcare facilities for storing, retrieving, and displaying medical images. In addition to its health care interests, Solborn holds stakes in Focus Newspaper Co., Ltd., a company involved in newspaper publishing, advertising, and printing businesses. The group also includes Solborn Investment Co., Ltd., which focuses on venture investment activities, thereby diversifying the parent company's financial exposure across different economic sectors. Beyond its equity investments, Solborn operates a rental business segment. This division involves the leasing of real estate assets, specifically including CHEONG DAM SPOPIA, which is described as a golf park. The company also leases industrial real estates, adding a tangible asset component to its revenue streams. The combination of healthcare technology manufacturing, media publishing, venture capital, and real estate leasing illustrates a multifaceted corporate structure. While the parent company itself does not directly manufacture medical devices or publish newspapers, its strategic shareholdings allow it to influence and benefit from the operations of these specialized subsidiaries. The company's long-standing presence in the market, evidenced by its 1999 IPO, suggests an established history of navigating the South Korean business landscape. Its small workforce indicates a lean operational model, likely relying on the management structures of its subsidiaries to execute day-to-day business activities while the parent company focuses on high-level strategic oversight and financial management. Solborn is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Solborn's Equity

Solborn's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Solborn's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Solborn's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Solborn's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Solborn’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Solborn stock

The Equity of Solborn is 212.61 B KRW in 2025.

The Equity of Solborn changed from 206.50 B KRW to 212.61 B KRW, representing a 2.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Solborn since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Solborn historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Solborn

All Key Metrics — Solborn